Acadia (ACHC) Buys CTCs to Boost Care Access in North Carolina

Core Insights - Acadia Healthcare Company, Inc. has recently acquired three comprehensive treatment centers in North Carolina, enhancing its footprint in the state [1][2][3] - The newly acquired centers will provide medication-assisted treatment programs combined with behavioral therapy and support services for opioid addiction [1][2] - Acadia Healthcare's revenue from comprehensive treatment centers reached $500.2 million in 2023, reflecting a 19.1% year-over-year increase, and these centers accounted for 17% of the company's overall revenue [4] Expansion Strategy - The acquisition aligns with Acadia's strategy to expand its presence in North Carolina, where it now operates 10 centers, and aims to open up to 14 additional centers in 2024 [2][4] - The company is also involved in joint ventures with U.S. health systems to add approximately 800 beds through new and existing facilities in 2024 [4] Market Context - The ongoing opioid use disorder crisis is expected to sustain demand for Acadia's treatment centers, indicating a favorable market environment for the company's services [2][4] - Acadia's stock performance has been less favorable compared to the industry, with shares rising 8.9% over the past six months, while the industry saw a growth of 36.1% [4]